Structural heart imaging market seen reaching $27.02 billion by 2030

The Business Research Company says the structural heart imaging market is set to grow from $17.09 billion in 2025 to $27.02 billion by 2030, driven by demand for minimally invasive cardiac procedures and AI-enabled imaging. North America led in 2025, while Asia-Pacific is projected to be the fastest-growing region.

Why it matters: - Structural heart imaging is becoming more important as hospitals and cardiology teams look for more precise tools to diagnose valve disease and congenital heart defects. - The market’s growth reflects rising cardiovascular disease rates and a broader shift toward minimally invasive cardiac care. - Better imaging can improve pre-procedure planning, real-time guidance during interventions and post-treatment monitoring.

What happened: - The Business Research Company published its Structural Heart Imaging Global Market Report 2026, covering market size, trends and forecasts through 2035. - The report pegs the market at $17.09 billion in 2025 and $18.75 billion in 2026. - The report forecasts the market will reach $27.02 billion by 2030. - North America held the largest market share in 2025. - Asia-Pacific is projected to be the fastest-growing region over the forecast period.

The details: - The report says growth is being driven by the rising prevalence of structural heart diseases. - Broader adoption of transcatheter cardiac procedures is supporting demand. - Advances in echocardiography and CT imaging are expanding use cases. - Imaging is being used more often in interventional cardiology and catheter-based therapies. - The report points to stronger demand for minimally invasive cardiac interventions as a major driver through 2030. - Other expected growth drivers include investment in intelligent cardiac imaging platforms and wider use of AI-assisted diagnostic imaging. - The report also highlights more imaging use in complex valve procedures and a greater focus on improving procedural outcomes. - Expected market trends include real-time image-guided cardiac interventions, multimodality imaging systems, AI-based image analysis, advanced 3D and 4D visualization, and better pre-procedural planning. - The report defines structural heart imaging as specialized medical imaging of the heart’s valves, walls and chambers. - The report says the technology is used to diagnose valve defects and congenital heart abnormalities. - The report says clinicians use structural heart imaging for pre-procedural planning, live guidance during interventions and post-treatment evaluation. - The report says the Asia-Pacific market is gaining from higher healthcare investment, rising cardiovascular awareness and broader access to advanced cardiac care. - The analysis covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

Between the lines: - Rising cardiovascular death rates add urgency to better diagnostics and treatment planning. - The American Heart Association said the U.S. age-adjusted cardiovascular disease death rate rose to 233.3 per 100,000 people in January 2024 from 224.4 per 100,000 in 2023, a 4.0% increase. - The report’s focus on AI and advanced visualization suggests the next phase of competition may center on workflow speed, imaging precision and procedural outcomes rather than hardware alone.

What's next: - The market is expected to keep expanding through 2030 as hospitals adopt more advanced imaging tools for complex cardiac procedures. - The report points to further growth in AI-assisted imaging, 3D and 4D visualization, and real-time guidance systems. - The Business Research Company also added new 2026 report features, including TAM analysis, company scoring matrices, forecasting dashboards, hotspot infographics and updated graphics and tables. - The company is offering a free sample report and the full report through its website.

The bottom line: - Structural heart imaging is moving from a specialized diagnostic tool to a core part of modern cardiac intervention, with growth driven by disease burden, minimally invasive procedures and smarter imaging software.